Quantization effects in the polyphase N-path IIR structure

Polyphase IIR structures have recently proven themselves very attractive for very high performance filters that can be designed using very few coefficients. This, combined with their low sensitivity to coefficient quantization in comparison to standard FIR and IIR structures, makes them very applicable for very fast filtering when implemented in fixed-point arithmetic. However, although the mathematical description is very simple, there exist a number of ways to implement such filters. In this paper, we take four of these different implementation structures, analyze the rounding noise originating from the limited arithmetic wordlength of the mathematical operators, and check the internal data growth within the structure. These analyses need to be done to ensure that the performance of the implementation matches the performance of the theoretical design. The theoretical approach that we present has been proven by the results of the fixed-point simulation done in Simulink and verified by an equivalent bit-true implementation in VHDL.

Adaptive-threshold region merging via path scanning

Region merging algorithms commonly produce results that are seen to be far below the current commonly accepted state-of-the-art image segmentation techniques. The main challenging problem is the selection of an appropriate and computationally efficient method to control resolution and region homogeneity. In this paper we present a region merging algorithm that includes a semi-greedy criterion and an adaptive threshold to control segmentation resolution. In addition we present a new relative performance indicator that compares algorithm performance across many metrics against the results from human segmentation. Qualitative (visual) comparison demonstrates that our method produces results that outperform existing leading techniques.

Cadherin-5: a biomarker for metastatic breast cancer with optimum efficacy in oestrogen receptor-positive breast cancers with vascular invasion

Background: A glycoproteomic study has previously shown cadherin-5 (CDH5) to be a serological marker of metastatic breast cancer when both protein levels and glycosylation status were assessed. In this study we aimed to further validate the utility of CDH5 as a biomarker for breast cancer progression. Methods: A nested case–control study of serum samples from breast cancer patients, of which n=52 had developed a distant metastatic recurrence within 5 years post-diagnosis and n=60 had remained recurrence-free. ELISAs were used to quantify patient serum CDH5 levels and assess glycosylation by Helix pomatia agglutinin (HPA) binding. Clinicopathological, treatment and lifestyle factors associated with metastasis and elevated biomarker levels were identified. Results: Elevated CDH5 levels (P=0.028) and ratios of CDH5:HPA binding (P=0.007) distinguished patients with metastatic disease from those that remained metastasis-free. Multivariate analysis showed that the association between CDH5:HPA ratio and the formation of distant metastases was driven by patients with oestrogen receptor (ER+) positive cancer with vascular invasion (VI+). Conclusions: CDH5 levels and the CDH5 glycosylation represent biomarker tests that distinguish patients with metastatic breast cancer from those that remain metastasis-free. The test reached optimal sensitivity and specificity in ER-positive cancers with vascular invasion.